Durability Study With PulseSelect Pulsed Field Ablation (PFA) System and Real-World Experience
Published: 01 November 2024
-
Views:
5489
-
Likes:
7
-
Views:
5489
-
Likes:
7
-
18m 14sPart 4 Panel Discussion and Q&A
-
3m 8sPart 1 Welcome Khaldoun G Tarakji, Devi Nair, Gaurang Gandhi
-
19m 38sPart 2 Lesion Durability and Workflow Devi Nair
Overview
This program features presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. Faculty also discuss efficiency workflow tips and a multi-user center’s real-world experience.
UC202503229 EN
Learning Objectives
- Review recently presented data on durability with PulseSelect PFA Ablation Catheter
- Discuss procedural efficiency workflow tips while using PFA
- Evaluate a standardized usage in a multi-user experience to ensure consistent and high-quality procedures
Target Audience
- Electrophysiologists
- Cardiologists
- Fellows
- Allied Healthcare Professionals
More from this programme
Part 1
Welcome
Part 2
Lesion Durability and Workflow
Dr Devi Nair offers a comprehensive overview of lesion durability and workflow with the PulseSelect™ PFA System.
| 1 session | |
| Lesion Durability and Workflow | Watch now |
Part 3
Standardized Workflow in a Multi-operator Center
Dr Gaurang Gandhi discusses the implementation of a standardized workflow in a multi-operator center.
Part 4
Panel Discussion and Q&A
The faculty answer audience questions, offer expert insights and participate in an interactive discussion.
| 1 session | |
| Panel Discussion and Q&A | Watch now |
Faculty Biographies
Gaurang Gandhi
Electrophysiologist
Dr Gaurang Gandhi is an Electrophysiologist at TriHealth Heart & Vascular Institute, Ohio, US.
Over the past 15 years, he has treated adults with cardiovascular disease, with a specialised focus on arrhythmia and other forms of irregular heartbeats.
Dr Gandhi assesses and manages patients with various heart conditions, including arrhythmias such as SVT, VT, atrial flutter and atrial fibrillation, as well as concerns like the risk of sudden cardiac death, heart failure and fainting (syncope).